Newsroom
Sorted by: Latest
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Unity Announces Fourth Quarter and Fiscal Year 2025 Financial Results Webcast
SAN FRANCISCO--(BUSINESS WIRE)--Unity (NYSE: U) announced today it will release fourth quarter and fiscal year 2025 financial results before the market opens on February 11, 2026, with a webcast to follow at 8:30 a.m. ET/5:30 a.m. PT. The webcast and financial results will be accessible at investors.unity.com. A replay of the webcast will also be available on Unity’s Investor Relations website. About Unity Software Inc. (Unity) Unity [NYSE: U] offers a suite of tools to develop, deploy, and gro...
-
Monnai Raises $12 Million in Equity Funding to Build the Global Standard for Identity and Risk Decisioning
LOS ANGELES--(BUSINESS WIRE)--Monnai announces a $12M funding round, led by Motive Partners, to scale its identity and risk data infrastructure....
-
Dr. Reddy’s Announces the First-to-Market Launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the Generic Equivalent of Extra-Strength Pataday® Once Daily Relief, in the U.S.
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s launched Olopatadine Hydrochloride Ophthalmic Solution USP 0.7% (OTC), a generic equivalent of Extra-Strength Pataday® Once Daily Relief....
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Fortem Technologies Welcomes JIATF-401’s Selection of DroneHunter as First Replicator 2 Purchase
LINDON, Utah--(BUSINESS WIRE)--Fortem Technologies, the global leader in airspace security and counter-drone solutions, today welcomed the U.S. Department of War’s announcement that Joint Interagency Task Force 401 (JIATF-401) has selected the company’s DroneHunter® interceptor as the first purchase under Replicator 2, a fast-track effort designed to move deployable counter-drone systems into operational use quickly. “This selection is a powerful vote of confidence in DroneHunter’s operational...
-
flyExclusive Acquires Two Additional Challenger 350 Aircraft Advancing Fleet Modernization and High-Contribution Growth in 2026
KINSTON, N.C.--(BUSINESS WIRE)--flyExclusive (NYSE American: FLYX) today announced the addition of two Challenger 350 aircraft to its fleet, continuing its planned expansion of high-contribution super-midsize capacity as part of the company’s 2026 fleet modernization and growth roadmap. The additions bring flyExclusive’s Challenger fleet to eight aircraft, marking another milestone in the Company’s multi-year strategy to deploy capital into aircraft categories that deliver the strongest utiliza...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Armstrong World Industries Announces President and CEO Vic Grizzle to Transition to Executive Chair and Mark Hershey to Become President and CEO Effective April 1, 2026
LANCASTER, Pa.--(BUSINESS WIRE)--Armstrong World Industries, Inc. (NYSE:AWI), an Americas leader in the design and manufacture of innovative interior and exterior architectural applications including ceilings, specialty walls and exterior metal solutions, announced today that the company’s President and CEO Vic Grizzle will transition to Executive Chair, and that current Senior Vice President and Chief Operating Officer Mark Hershey will succeed Grizzle as CEO and President effective April 1, 2...